Manufacturer
SM PHARMACEUTICALS SDN. BHD.
Contents
Each chewable tab contains aluminium hydroxide 160 mg and magnesium hydroxide 105 mg
Indication
Gastrointestinal hyperacidity.
Instruction
2-4 tab 4 times/day or as required. Max: 16 tab/24 hours.
Drug interaction
Interferes with the absorption of ciprofloxacin, chloroquine, hydroxychloroquine, chlorpromazine, cefdinir, cefpodoxime, ketoconazole, levothyroxine, rifampicin, rosuvastatin, tetracyclines, vitamins. May reduce the effect of polystyrene sulphonate. Decreased serum concentration of velpatasvir. Increased absorption with citrate-containing preparations. May decrease absorption of Fe salts.
Magnesium hydroxide: Increases the excretion of salicylates.
Malaysia
